GSA Capital Partners’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,891
| Closed | -$231K | – | 1982 |
|
|
2025
Q2 | $231K | Buy |
+2,891
| New | +$242K | 0.02% | 1427 |
|
|
2025
Q1 | – | Sell |
-49,181
| Closed | -$3.84M | – | 1978 |
|
|
2024
Q4 | $3.84M | Buy |
49,181
+9,256
| +23% | +$719K | 0.28% | 19 |
|
|
2024
Q3 | $2.88M | Sell |
39,925
-13,679
| -26% | -$969K | 0.22% | 41 |
|
|
2024
Q2 | $3.69M | Buy |
53,604
+47,700
| +808% | +$3.23M | 0.26% | 21 |
|
|
2024
Q1 | $428K | Buy |
+5,904
| New | +$395K | 0.03% | 986 |
|
|
2023
Q1 | – | Sell |
-5,806
| Closed | -$363K | – | 1822 |
|
|
2022
Q4 | $363K | Sell |
5,806
-6,441
| -53% | -$369K | 0.05% | 806 |
|
|
2022
Q3 | $610K | Buy |
12,247
+5,457
| +80% | +$302K | 0.08% | 431 |
|
|
2022
Q2 | $399K | Buy |
+6,790
| New | +$374K | 0.06% | 640 |
|
|
2021
Q3 | – | Sell |
-6,045
| Closed | -$315K | – | 1695 |
|
|
2021
Q2 | $315K | Buy |
+6,045
| New | +$290K | 0.04% | 915 |
|
|
2021
Q1 | – | Sell |
-6,321
| Closed | -$220K | – | 1384 |
|
|
2020
Q4 | $220K | Buy |
+6,321
| New | +$224K | 0.04% | 926 |
|
|
2020
Q2 | – | Sell |
-17,362
| Closed | -$637K | – | 985 |
|
|
2020
Q1 | $637K | Buy |
17,362
+9,662
| +125% | +$375K | 0.16% | 78 |
|
|
2019
Q4 | $312K | Sell |
7,700
-1,800
| -19% | -$67.1K | 0.04% | 997 |
|
|
2019
Q3 | $330K | Buy |
+9,500
| New | +$313K | 0.04% | 817 |
|
|
2019
Q2 | – | Sell |
-26,300
| Closed | -$787K | – | 1668 |
|
|
2019
Q1 | $787K | Sell |
26,300
-9,000
| -25% | -$258K | 0.08% | 422 |
|
|
2018
Q4 | $1.09M | Buy |
35,300
+20,505
| +139% | +$748K | 0.13% | 178 |
|
|
2018
Q3 | $561K | Buy |
+14,795
| New | +$560K | 0.03% | 1013 |
|
|
2018
Q2 | – | Sell |
-33,175
| Closed | -$1.12M | – | 1868 |
|
|
2018
Q1 | $1.12M | Buy |
+33,175
| New | +$1.27M | 0.06% | 585 |
|
|
2017
Q3 | – | Sell |
-13,075
| Closed | -$690K | – | 1822 |
|
|
2017
Q2 | $690K | Buy |
+13,075
| New | +$701K | 0.05% | 794 |
|
|
2017
Q1 | – | Sell |
-5,355
| Closed | -$279K | – | 1930 |
|
|
2016
Q4 | $279K | Buy |
+5,355
| New | +$258K | 0.02% | 1371 |
|
|
2016
Q3 | – | Sell |
-22,580
| Closed | -$1.25M | – | 1910 |
|
|
2016
Q2 | $1.25M | Buy |
22,580
+15,766
| +231% | +$868K | 0.07% | 496 |
|
|
2016
Q1 | $364K | Sell |
6,814
-21,106
| -76% | -$1.04M | 0.02% | 1204 |
|
|
2015
Q4 | $1.44M | Buy |
27,920
+7,328
| +36% | +$364K | 0.07% | 449 |
|
|
2015
Q3 | $930K | Buy |
+20,592
| New | +$973K | 0.05% | 697 |
|
|
2015
Q2 | – | Sell |
-11,308
| Closed | -$485K | – | 2130 |
|
|
2015
Q1 | $485K | Buy |
+11,308
| New | +$431K | 0.02% | 1406 |
|
|
2014
Q3 | – | Sell |
-15,440
| Closed | -$523K | – | 1882 |
|
|
2014
Q2 | $523K | Sell |
15,440
-18,732
| -55% | -$600K | 0.02% | 1117 |
|
|
2014
Q1 | $931K | Buy |
+34,172
| New | +$1.02M | 0.07% | 371 |
|
Other funds holding PBH
AI
WHG
GSA Capital Partners's PBH Position: Q3 2025 in Review
GSA Capital Partners sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 2,891 shares — an estimated $231K sold.
GSA Capital Partners first reported a position in PBH in Q1 2014 and held it in 26 quarters. The position peaked at $3.84M in Q4 2024. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.
- GSA Capital Partners reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
- GSA Capital Partners sold 2,891 Prestige Consumer Healthcare shares in Q3 2025, an estimated $231K.
- GSA Capital Partners first reported a position in Prestige Consumer Healthcare in Q1 2014 and held it in 26 quarters.
- GSA Capital Partners's Prestige Consumer Healthcare position peaked at $3.84M in Q4 2024.
- 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.
Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.